insights_auto
Bakit tumaas ang DBV 7.34%?
Tingnan ang Higit pang Detalyechevron_right
DBV:EPA
DBV Technologies SA
€1.71
arrow_upward
+7.34%(+0.12) 1D
Okt 20, 5:35:07 PM GMT+2 · EUR
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa DBV...
Buksan
€1.60
Mataas
€1.71
Mababa
€1.58
Mkt. cap
554.35M
Avg. na dami
1.11M
Dami
1.32M
Mataas nang 52-wk
€4.50
Mababa nang 52-wk
€1.55
EPS
-€0.64
Mga natitirang share
314.39M
Bilang ng mga empleyado
170
Buksan
€1.60
Mataas
€1.71
Mababa
€1.58
Mkt. cap
554.35M
Avg. na dami
1.11M
Dami
1.32M
Mataas nang 52-wk
€4.50
Mababa nang 52-wk
€1.55
EPS
-€0.64
Mga natitirang share
314.39M
Bilang ng mga empleyado
170
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
MarketWatch
·
3 araw ang nakalipas
It was another great week for the average stock as market leadership shifts away from tech
24/7 Wall St.
·
6 araw ang nakalipas
These 3 International Dividend ETFs Outyield SCHD and Are Beating the S&P 500 Over the Past Year
FXStreet
·
5 araw ang nakalipas
Dow Jones futures gains ahead of US PPI, Retail Sales data
Reuters
·
1 buwan ang nakalipas
S&P 500 ends down as oil tops $100 per barrel
Profile
DBV Technologies SA is a publicly owned French biopharmaceutical firm headquartered in Bagneux, France. DBV Technologies is known for developing "Viaskin" technology for administering allergens or antigens to intact skin while avoiding any transfer to the blood. Viaskin Peanut clinical development has received Fast Track designation from the US Food and Drug Administration. Wikipedia
Tungkol sa DBV Technologies SA